Cell-Free DNA as Alternative to Bone Marrow CD19+Selection for Diagnostic MYD88 L265P in Waldenstrom's Macroglobulinemia

被引：0

作者：

Demos, Maria ^{[1
]}

Xu, Lian ^{[1
]}

Tsakmaklis, Nickolas ^{[1
]}

Kofides, Amanda ^{[1
]}

Chen, Jiaji ^{[1
]}

Munshi, Manit ^{[1
]}

Liu, Xia ^{[1
]}

Jimenez, Cristina ^{[1
]}

Chan, Gloria ^{[1
]}

Guerrera, Maria Luisa ^{[1
]}

Meid, Kirsten ^{[1
]}

Keezer, Andrew ^{[1
]}

Yang, Guang ^{[1
]}

Hunter, Zachary ^{[1
]}

Castillo, Jorge ^{[1
]}

Treon, Steven ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期

关键词：

cell-free DNA; MYD88; Waldenstrom macroglobulinemia;

D O I：

10.1016/j.clml.2019.09.511

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

SP-185

引用

页码：E311 / E311

页数：1

共 50 条

[41] New Anti-Cancer Drug Compounds to Treat Mutated Waldenstrom Myd88 L265P
Oliva, Joan
Villanueva, Larakaye
Ochiai, Jun
Niihara, Yutaka
BLOOD, 2021, 138
[42] Rare Circulating Cells in Familial Waldenstrom Macroglobulinemia Displaying the MYD88 L265P Mutation Are Enriched by Epstein-Barr Virus Immortalization
Pertesi, Maroulio
Galia, Perrine
Nazaret, Nicolas
Vallee, Maxime
Garderet, Laurent
Leleu, Xavier
Avet-Loiseau, Herve
Foll, Matthieu
Byrnes, Graham
Lachuer, Joel
Mckay, James D.
Dumontet, Charles
PLOS ONE, 2015, 10 (09):
[43] IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstrom macroglobulinemia/lymphoplasmacytic lymphomas
Gachard, N.
Parrens, M.
Soubeyran, I.
Petit, B.
Marfak, A.
Rizzo, D.
Devesa, M.
Delage-Corre, M.
Coste, V.
Laforet, M. P.
de Mascarel, A.
Merlio, J. P.
Bouabdhalla, K.
Milpied, N.
Soubeyran, P.
Schmitt, A.
Bordessoule, D.
Cogne, M.
Feuillard, J.
LEUKEMIA, 2013, 27 (01) : 183 - 189
[44] Bing-Neel Syndrome with Detectable MYD88 L265P Gene Mutation as a Late Relapse Following Autologous Hematopoietic Stem Cell Transplantation for Waldenstrom's Macroglobulinemia
Kopinska, Anna J.
Helbig, Grzegorz
Koclega, Anna
Kyrcz-Krzemien, Slawomira
TURKISH JOURNAL OF HEMATOLOGY, 2017, 34 (02) : 186 - 187
[45] Absence of MYD88 L265P mutation in blastic plasmacytoid dendritic cell neoplasm
Fiandrino, G.
Arra, M.
Riboni, R.
Lucioni, M.
Dallera, E.
Arcaini, L.
Berti, E.
Paulli, M.
BRITISH JOURNAL OF DERMATOLOGY, 2013, 168 (04) : 883 - 884
[46] Combining MYD88 L265P mutation detection and clonality determination on CSF cellular and cell-free DNA improves diagnosis of primary CNS lymphoma
Bravetti, Clotilde
Degaud, Michael
Armand, Marine
Sourdeau, Elise
Mokhtari, Karima
Maloum, Karim
Osman, Jennifer
Verrier, Patricia
Houillier, Caroline
Roos-Weil, Damien
Soussain, Carole
Choquet, Sylvain
Hoang-Xuan, Khe
Le Garff-Tavernier, Magali
Denis, Jerome Alexandre
Davi, Frederic
BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 (06) : 1088 - 1096
[47] MYD88 (L265P) Somatic Mutation: Utility in the Differential Diagnosis of Bone Marrow Involvement by B-Cell Lymphoproliferative Disorders
Ondrejka, S. L.
Lin, J.
Warden, D. W.
Durkin, L.
Cook, J. R.
Hsi, E. D.
MODERN PATHOLOGY, 2013, 26 : 354A - 354A
[48] Detection of the MYD88 L265P Mutation in Paraffin-Embedded Bone Marrow Biopsies of Small B-Cell NHL
Schmidt, J.
Schindler, N.
Bonzheim, I.
Federmann, B.
Fend, F.
Quintanilla-Martinez, L.
LABORATORY INVESTIGATION, 2014, 94 : 376A - 376A
[49] MYD88 (L265P) Somatic Mutation: Utility in the Differential Diagnosis of Bone Marrow Involvement by B-Cell Lymphoproliferative Disorders
Ondrejka, S. L.
Lin, J.
Warden, D. W.
Durkin, L.
Cook, J. R.
Hsi, E. D.
LABORATORY INVESTIGATION, 2013, 93 : 354A - 354A
[50] Detection of the MYD88 L265P Mutation in Paraffin-Embedded Bone Marrow Biopsies of Small B-Cell NHL
Schmidt, J.
Schindler, N.
Bonzheim, I.
Federmann, B.
Fend, F.
Quintanilla-Martinez, L.
MODERN PATHOLOGY, 2014, 27 : 376A - 376A

← 1 2 3 4 5 →